You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

PEMETREXED DITROMETHAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pemetrexed Ditromethamine patents expire, and when can generic versions of Pemetrexed Ditromethamine launch?

Pemetrexed Ditromethamine is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in PEMETREXED DITROMETHAMINE is pemetrexed ditromethamine. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pemetrexed ditromethamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pemetrexed Ditromethamine

A generic version of PEMETREXED DITROMETHAMINE was approved as pemetrexed ditromethamine by HOSPIRA on June 10th, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PEMETREXED DITROMETHAMINE?
  • What are the global sales for PEMETREXED DITROMETHAMINE?
  • What is Average Wholesale Price for PEMETREXED DITROMETHAMINE?
Summary for PEMETREXED DITROMETHAMINE
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:PEMETREXED DITROMETHAMINE at DailyMed
Drug patent expirations by year for PEMETREXED DITROMETHAMINE
Pharmacology for PEMETREXED DITROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for PEMETREXED DITROMETHAMINE

US Patents and Regulatory Information for PEMETREXED DITROMETHAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira PEMETREXED DITROMETHAMINE pemetrexed ditromethamine POWDER;INTRAVENOUS 208746-003 Jun 10, 2022 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PEMETREXED DITROMETHAMINE pemetrexed ditromethamine POWDER;INTRAVENOUS 208746-001 Jun 10, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PEMETREXED DITROMETHAMINE pemetrexed ditromethamine POWDER;INTRAVENOUS 208746-002 Jun 10, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.